Resistance Patterns in HIV-2 Infection: A Case Report
Author Information
Author(s): van Kampen Jeroen J A, van Nood Els, Mahmud Rizwan, Krullaars Zoë, Voskamp Tess, Voskamp Mike, Nijssen Tess, Voermans Jolanda J C, Charpentier Charlotte, Le Hingrat Quentin, van de Vijver David, Gruters Rob, Mesplède Thibault
Primary Institution: Erasmus MC, Rotterdam, The Netherlands
Hypothesis
What are the resistance patterns of HIV-2 to dolutegravir and lenacapavir?
Conclusion
Lenacapavir shows potential in treating HIV-2 but must be combined with other effective antiretroviral agents to prevent resistance.
Supporting Evidence
- Lenacapavir was added to a failing regimen, initially reducing viral load.
- Resistance mutations were identified during treatment.
- The patient experienced a rebound in viral load despite initial improvements.
Takeaway
This study looks at a patient with HIV-2 who had trouble getting better with certain medicines, but found some new options that helped a little.
Methodology
The case of a treatment-experienced individual was reported, including clinical monitoring and resistance assays.
Potential Biases
Potential conflicts of interest were reported for some authors.
Limitations
The study is based on a single case, limiting generalizability.
Participant Demographics
An adult female diagnosed with HIV-2 in 2002.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website